期刊文献+

高血压患者颈动脉粥样硬化与血清C-肽、唾液酸的关系 被引量:1

The relation between carotid atherosclerosis and serum C-peptide and sialic acid in hypertensive patients
下载PDF
导出
摘要 目的探讨原发性高血压(EH)患者颈动脉粥样硬化(CAS)与C-肽、唾液酸的关系。方法收集50例EH伴CAS患者和43例EH不伴CAS患者的人体学指标、既往史、实验室检测和骨密度检查数据,进行统计学分析。结果 EH伴CAS组与EH不伴CAS组比较,C-肽、唾液酸、胰岛素、C反应蛋白、血尿酸、年龄、舒张压、脉压差、吸烟、冠心病和骨质疏松发生率等因素差异有统计学意义(P<0.05),多因素分析显示,年龄、吸烟(少量)、唾液酸和C-肽是CAS的独立危险因素。结论 EH患者C-肽、唾液酸等指标与CAS关系密切,并参与了CAS的发生发展。 Objective To investigate the relation between carotid atherosclerosis(CAS) in essential hypertension(EH) patients and C-peptide and sialic acid.Methods The main anthropometry index,past medical history,the data of laboratory detection and bone mineral density from 50 EH cases with CAS and 43 EH cases without CAS were collected and analyzed statistically.Results There were significant difference in C-peptide,SA,INS,CRP,UA,age,DBP,PP,smoking,coronary heart disease and the prevalence of osteoporosis between the group of 50 EH cases with CAS and 43 EH without CAS cases(P〈0.05).The age,smoking,SA and C-peptide were the independent risk factors after multivariate analysis.Conclusion There is a close relationship between carotid atherosclerosis of hypertensive patients and serum C-peptide,sialic acid.These factors are involved in the development of CAS.
出处 《东南国防医药》 2011年第1期34-36,共3页 Military Medical Journal of Southeast China
关键词 高血压病 颈动脉粥样硬化 C-肽 唾液酸 hypertension carotid atherosclerosis C-peptide sialic acid
  • 相关文献

参考文献11

二级参考文献41

  • 1全国高血压,冠心病与糖尿病专题研讨会纪要[J].中华心血管病杂志,1993,21(5):260-265. 被引量:105
  • 2陈宇红,张翼飞,詹维伟,洪洁,顾卫琼,桂明辉,杨义生,宁光.早期动脉硬化与不同糖耐量状态的相关性[J].中华内分泌代谢杂志,2005,21(4):353-356. 被引量:8
  • 3无,龚兰生,许玉韵,张维忠,刘望彭,王新房,王宏宇,张瑞岩,郭远,李运田,马志敏,芦娜,倪永斌,王敏,杨娅,何建国,高旭光,丁康,沈晨阳,陈生龙,史旭波,陶军.中国血管病变早期检测技术应用指南(第一次报告)[J].中国民康医学,2006,18(9):323-331. 被引量:94
  • 4侯俊秀,李彩萍,赵杰.老年代谢综合征颈动脉粥样硬化特征的研究[J].中华老年多器官疾病杂志,2007,6(2):113-116. 被引量:15
  • 5Johansson BL, Kernell A, Sjoberg S,et al. Inffluence of combined cpeptide and insulin administration on renal function and metabolic control in diabetes type 1 [ J]. J Clin Endoerinol Metab, 1993, 77: 976 - 981
  • 6Samnegard B, Jacobson SH, Jaremko G, et al. C-peptide prevents glomerular hypertrophy and mesangial matrix in diabetic rats [ J ]. Nephrol Dial Transplant, 2005,20 : 532 - 538
  • 7Ido Y, Vindigni A , Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide[ J]. Science, 1997, 277 (5325) :563-566
  • 8Sari R,Balsi MK. Relationship between C-peptide and chronic complications in type-2 diabetes mellitus. Journal of the National Medical Association[ J]. 2005,97 : 1113 - 1118
  • 9Tsimaratos M, Roger F, Chabardes D, et al. C-peptide stimulates Na^+-K^+-ATPase activity via PKC alpha in rat medullary thick ascending limb[ J]. Diabetologia, 2003, 46( 1 ) : 124 - 131
  • 10Sima AA, Zhang W, Grunberger G. Type 1 diabetic neuropathy and C-peptide. Exp Diabesity Res[J]. 2004,5(1 ) :65-77

共引文献453

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部